1. Home
  2. WBX vs TENX Comparison

WBX vs TENX Comparison

Compare WBX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.80

Market Cap

63.8M

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.78

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
TENX
Founded
2015
1967
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.8M
74.1M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
WBX
TENX
Price
$2.80
$1.78
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$4.00
★ $9.63
AVG Volume (30 Days)
8.5K
★ 1.9M
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$142.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.30
$1.31
52 Week High
$6.18
$19.40

Technical Indicators

Market Signals
Indicator
WBX
TENX
Relative Strength Index (RSI) 44.92 43.74
Support Level $2.64 $1.34
Resistance Level $3.10 $2.00
Average True Range (ATR) 0.12 0.14
MACD 0.03 0.09
Stochastic Oscillator 50.57 63.08

Price Performance

Historical Comparison
WBX
TENX

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: